![]() |
市場調查報告書
商品編碼
1492503
細胞冷凍介質市場:按類型、應用和最終用途分類 - 2024-2030 年全球預測Cell Freezing Media Market by Type (Dimethyl Sulfoxide-based Media, Glycerol-Based Media, Serum-Free Media), Application (Biobanking, Cancer Research, Genetic Engineering & CRISPR Technology), End-Use - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
細胞冷凍介質市場規模預計2023年為1.8571億美元,2024年達到2.0166億美元,預計2030年將達到3.3325億美元,複合年成長率為8.71%。
細胞冷凍介質是一種在極低溫下儲存細胞的專用解決方案。二甲基亞碸(DMSO) 和甘油等冷凍保護劑的均衡混合物可保護細胞在冷凍過程中免受結晶形成。這些冷凍保護劑對於最大限度地減少細胞損傷並在解凍過程中維持細胞活力和功能至關重要。對先進生物製藥的需求不斷成長以及細胞治療領域的成長進一步促進了細胞冷凍介質市場的繁榮。這些治療方法在很大程度上依賴細胞保存,有效的冷凍介質的作用至關重要。然而,先進保存技術的高成本以及細胞處理和儲存的嚴格監管要求給製造商和供應商帶來了巨大的挑戰。企業在這種環境中保持敏捷,努力降低成本並遵守法規。客製化冷凍解決方案的開發、新興市場的成長以及人工智慧和物聯網等最尖端科技的整合以改善冷凍保存結果都可以看到擴展機會。
主要市場統計 | |
---|---|
基準年[2023] | 1.8571 億美元 |
預測年份 [2024] | 20166萬美元 |
預測年份 [2030] | 33325萬美元 |
複合年成長率(%) | 8.71% |
區域洞察
美國和加拿大因其強大的生物技術領域、大量的研發投資以及大型製藥公司的存在而處於細胞冷凍介質市場的前沿。與冷凍保存技術和配方相關的創新和專利經常被報導,顯示對先進細胞冷凍解決方案的高需求。細胞療法和再生醫學的採用進一步推動了該地區的市場成長。歐洲、中東和非洲細胞冷凍介質市場具有前瞻性,非常注重品質、創新和遵守嚴格的監管標準。該地區對幹細胞研究、個人化醫療和生物庫的關注促進了對複雜細胞冷凍解決方案的穩定需求。研究合作和歐盟資助的舉措在市場動態中發揮重要作用。隨著研究活動投資的增加,中東和非洲地區正在經歷適度的市場成長,並且對細胞療法的認知不斷增強,正在推動市場的發展。此外,由於生物技術的顯著進步以及對長期細胞保存的冷凍保存方法的日益青睞,亞太地區的細胞冷凍介質市場正在穩步擴張。研究和開發活動、生物庫的增加以及中國、日本和印度等國家對再生醫學需求的激增進一步推動了這種成長。此外,政府旨在加強醫療基礎設施和增加對製藥和生物製藥行業投資的措施也促進了市場的積極成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在細胞冷凍介質市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對細胞冷凍介質市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對細胞冷凍介質市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[187 Pages Report] The Cell Freezing Media Market size was estimated at USD 185.71 million in 2023 and expected to reach USD 201.66 million in 2024, at a CAGR 8.71% to reach USD 333.25 million by 2030.
Cell freezing media is a specialized solution to preserve cells in extremely low temperatures. It comprises a balanced mixture of cryoprotectants, such as dimethyl sulfoxide (DMSO) and glycerol, protecting the cells from ice crystal formation during freezing. These cryoprotectants are crucial in minimizing cellular damage and maintaining cell viability and functionality upon thawing. The surging demand for advanced biopharmaceuticals and the growing cell therapy sector further contribute to the positive trajectory of the cell freezing media market. These therapies rely extensively on the preservation of cells, making the role of effective freezing media indispensable. However, the high cost of advanced preservation technologies and stringent regulatory requirements for cell handling and storage pose significant challenges for manufacturers and suppliers. Companies frequently work towards cutting costs and adhering to regulations to remain agile within the landscape. Expansion opportunities are seen in developing customized freezing solutions, growth in emerging markets, and integrating cutting-edge technologies such as AI and IoT to refine cryopreservation outcomes.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 185.71 million |
Estimated Year [2024] | USD 201.66 million |
Forecast Year [2030] | USD 333.25 million |
CAGR (%) | 8.71% |
Regional Insights
In America, the United States, and Canada stand at the forefront of the cell-freezing media market, owing to its robust biotechnology sector, substantial research and development investments, and major pharmaceutical companies. Innovations and patents in cryopreservation techniques and formulations are frequently reported, demonstrating a high demand for advanced cell freezing solutions. Adopting cell therapy and regenerative medicine further propels market growth in the region. The EMEA market for cell freezing media is advanced, strongly emphasizing quality, innovation, and compliance with stringent regulatory standards. The region's focus on stem cell research, personalized medicine, and biobanking contribute to a steady demand for sophisticated cell freezing solutions. Research collaborations and EU-funded initiatives play a significant role in market dynamics. The Middle East and Africa region are experiencing gradual growth in the cell freezing media market with rising investment in research activities, and increasing awareness about cell-based therapies contributes to market evolution. Moreover, the Asia Pacific region is experiencing a robust expansion in the cell freezing media market, owing to significant advancements in biotechnology and an increasing inclination towards cryopreservation methods for long-term cell storage. A rise in research and development activities, biobanking, and a surge in demand for regenerative medicine across countries such as China, Japan, and India further fuels this growth. Additionally, government initiatives aimed at bolstering healthcare infrastructure, along with growing investments in the pharmaceutical and biopharmaceutical sectors, are contributing to the positive trajectory of the market.
Market Insights
The market dynamics represent an ever-changing landscape of the Cell Freezing Media Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cell Freezing Media Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cell Freezing Media Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Sartorius completes acquisition of Polyplus
Sartorius, an entity in the life sciences sector, completed the acquisition of Polyplus through its subsidiary, Sartorius Stedim Biotech. Polyplus specializes in developing and producing pivotal transfection reagents in viral vector manufacturing. This acquisition augments Sartorius's capabilities in this domain and signifies Polyplus's expansion into complementary technologies. By venturing into plasmid design and protein and plasmid production, Polyplus is diversifying its offerings and enhancing its technological portfolio to better serve the evolving needs of gene-modified cell and gene therapies. [Published On: 2023-07-18]
Qkine and Sartorius Partnership Delivers a Complete Workflow Solution for the Analysis of Advanced Cell Models
Qkine partnered with Sartorius to enrich stem cell and organoid research by integrating Qkine's expertise in creating bioactive growth factors and cytokines with Sartorius's advanced portfolio of cell analysis technologies. Sartorius, celebrated for accelerating life science research and pharmaceutical development, offers a broad spectrum of products, including reagents, assays, and pioneering technologies such as automated cell culture and live-cell imaging. This partnership is positioned to propel advancements in biologic discovery, streamline cell line development processes, and enhance the development of sophisticated cell models, thus delivering a holistic workflow solution to the scientific community. [Published On: 2023-07-06]
ExCell Bio Launches a New Factory in Uruguay
ExCell Biotechnology Co., Ltd. celebrated the opening of its new facility, ARTICA BIOTECH S.A. This significant milestone occurred within the Zonamerica Free Trade Zone on the northeastern outskirts of Montevideo, Uruguay. ExCell Bio has distinguished itself through its dedication to innovation in developing upstream tools for the biopharmaceutical industry. The inauguration of ARTICA BIOTECH S.A. marks the company's second establishment in Uruguay. ExCell Bio has achieved a significant position in China's market segment with its serum product line, underscoring its commitment to excellence and growing influence in the global marketplace. [Published On: 2023-05-04]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cell Freezing Media Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cell Freezing Media Market, highlighting leading vendors and their innovative profiles. These include Abcam Limited, AMSBIO, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BPS Bioscience, Inc., Capricorn Scientific, Carl Roth GmbH + Co. KG, Celprogen Corporation, Charles River Laboratories, Elabscience Bionovation Inc., ExCell Biotechnology Co., Ltd, Funakoshi Co., Ltd., HiMedia Laboratories, Merck KGaA, NIPPON Genetics EUROPE GmbH, PAN-Biotech GmbH, PromoCell GmbH, Qiagen NV, Sartorius AG, STEMCELL Technologies, Thermo Fisher Scientific Inc., and WELGENE Inc..
Market Segmentation & Coverage